Persones / Equip Humà

Marta Agüera Jorge

Buscador de publicacions

Publicacions

  • Font A, Agüera M, Rios-Barnés M, Gamell Fullà A, Moreno-Romo D, López-Ramos MG, Manuel Monsonis Cabedo, Fumadó V, Simó-Nebot S, García-Fontecha CG, Fortuny-Guasch C, Echeverría-Esnal D, Noguera-Julian A and Velasco E.

    Impact of paediatric antimicrobial stewardship program in haematogenous bone and joint infections.

    EUROPEAN JOURNAL OF PEDIATRICS . 184(7): 426-426. Nº de cites: 2

    [doi:10.1007/s00431-025-06258-7]

  • Alejandre-Galobardes C, Penela-Sánchez, D, Alsina, J, Agüera, M, Soler-García a, Moussalam, S, Munoz-Almagro C, Brotons-de los Reyes P, Cambra-Lasaosa FJ, Forner, OR, Balaguer-Gargallo M, Launes-Montana C and Jordán-García I.

    Impact of universal immunization program with monoclonal antibody nirsevimab on reducing the burden of serious bronchiolitis that need pediatric intensive care

    EUROPEAN JOURNAL OF PEDIATRICS . 183(9): 3897-3904. Nº de cites: 17

    [doi:10.1007/s00431-024-05634-z]

  • Agüera M, Soler-García a, Alejandre-Galobardes C, Moussalam-Merino S, Sala-Castellví P, Pons G, Penela-Sánchez D, González-Grado C, Alsina-Rosell J, Climent C, Esteva-Afonso C, Fortuny-Guasch C, Fernández de Sevilla-Estrach M, García-García JJ, Brotons-de los Reyes P, Balaguer A, Estrada J, Jordán-García I, Munoz-Almagro C and Launes-Montana C.

    Nirsevimab immunization's real-world effectiveness in preventing severe bronchiolitis: A test-negative case-control study

    PEDIATRIC ALLERGY AND IMMUNOLOGY . 35(6): . Nº de cites: 31

    [doi:10.1111/pai.14175]

  • Agüera M, Melé-Casas M, Molina MM, Pons-Odena M, Fernández de Sevilla-Estrach M, García-García JJ, Launes-Montana C and Monfort L.

    Safety and effectiveness of bubble continuous positive airway pressure as respiratory support for bronchiolitis in a pediatric ward

    EUROPEAN JOURNAL OF PEDIATRICS . 181(12): 4039-4047. Nº de cites: 12

    [doi:10.1007/s00431-022-04616-3]

  • Mengual-Chuliá B, Launes-Montana C, Cazorla E, López-Lacort M, Muñoz-Quiles C, Mira-Iglesias A, Agüera M, Penela-Sánchez D, Garcés-Sánchez M, Fernández-García C, Cervera H, Carballido-Fernández M, Pineda-Caplliure A, Mollar-Maseres J, Shalabi-Benavent M, Sanz-Herrero F, Díez-Domingo J, Munoz-Almagro C, Orrico-Sánchez A and López-Labrador FX.

    Genomic Surveillance of Respiratory Syncytial Virus (RSV) during 2023/2024 Nirsevimab prophylaxis, Eastern Spain, early results.

    CLINICAL MICROBIOLOGY AND INFECTION . : .

    [doi:10.1016/j.cmi.2026.04.003]